The Effectiveness of Text Support for Stopping Smoking in Pregnancy (MiQuit): Multi-Trial Pooled Analysis Investigating Effect Moderators and Mechanisms of Action

Joanne Emery,Jo Leonardi-Bee,Tim Coleman,Lisa McDaid,Felix Naughton

DOI: https://doi.org/10.1093/ntr/ntae026

2024-02-14

Abstract:Abstract Introduction Digital cessation support appeals to pregnant smokers. In two pooled RCTs, MiQuit, a pregnancy-specific tailored text messaging intervention, did not show effectiveness for validated prolonged abstinence. However, secondary outcomes and potential moderators and mediators have not been investigated. We aimed to determine, using pooled RCT data: (1) MiQuit effectiveness on a range of smoking outcomes; (2) whether baseline tobacco dependence or quit motivation moderate effectiveness; (3) whether hypothesized mechanisms of action (quitting determination, self-efficacy, baby harm beliefs, lapse prevention strategies) mediate effectiveness. Methods Pooled data analysis from two procedurally identical RCTs comparing MiQuit (N = 704) to usual care (N = 705). Participants were smokers, <25 weeks pregnant, recruited from 40 English antenatal clinics. Outcomes included self-reported 7-day abstinence at 4 weeks post-baseline and late pregnancy, and prolonged abstinence. Late pregnancy outcomes were also biochemically validated. We used hierarchical regression and structural equation modeling. Results MiQuit increased self-reported, 7-day abstinence at 4 weeks (OR = 1.73 [95% CI 1.10–2.74]) and was borderline significant at late pregnancy (OR = 1.34 [0.99–1.82]) but not for prolonged or validated outcomes. Effectiveness was not moderated by baseline dependence (heaviness of smoking “low” vs. “moderate–high”) or motivation (planning to quit ≤30 days [high] vs. >30 days [low]), but effects on self-reported outcomes were larger for the high motivation sub-group. MiQuit had a small effect on mean lapse prevention strategies (MiQuit 8.6 [SE 0.17], UC 8.1 [SE 0.17]; P = .030) but not other mechanisms. Conclusions MiQuit increased short-term but not prolonged or validated abstinence and may be most effective for those motivated to quit sooner. Implications Digital cessation support appeals to pregnant smokers. MiQuit, a tailored, theory-guided text messaging program for quitting smoking in pregnancy, has not shown effectiveness for validated prolonged abstinence in two previous RCTs but its impact on other smoking outcomes and potential mechanisms of action are unknown. When pooling trial data, MiQuit increased self-reported short-term abstinence, including making a quit attempt and abstinence at 4-week follow-up, but not late pregnancy, sustained, or validated abstinence. MiQuit appeared effective at late pregnancy for participants with high quitting motivation, but its mechanisms of action remain uncertain. Additional support components are likely required to enhance effectiveness.

public, environmental & occupational health,substance abuse

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate the effectiveness of a pregnancy - specific customized text - message intervention named MiQuit in helping pregnant women quit smoking. Specifically, the study aims to determine:

1. **The effectiveness of MiQuit on a range of smoking outcomes**: This includes self - reported 7 - day quit rate, quit rate in late pregnancy, and continuous quit rate.
2. **Whether baseline tobacco dependence or quit - smoking motivation moderates the effectiveness of MiQuit**: That is, whether these factors will affect the effect of MiQuit.
3. **Whether the hypothesized mechanisms of action (such as quit - smoking determination, self - efficacy, belief in harm to the baby, use of relapse - prevention strategies) mediate the effect of MiQuit**: That is, whether these mechanisms play an intermediary role between MiQuit and the quit - smoking effect.

### Research Background
Smoking in pregnancy (SIP) is an international public health problem and is a major cause of adverse pregnancy and infant health outcomes, such as premature birth, low birth weight, stillbirth, and sudden infant death syndrome. More than half of smokers attempt to quit during pregnancy, but most quit - smoking attempts are not supported, greatly reducing the chances of success. Although the smoking - cessation support provided by the National Health Service (NHS) in the UK is very effective, the participation rate is low. Digital self - help smoking - cessation support, such as that provided through computers or smartphones, is attractive to pregnant women smokers and there is evidence of its effectiveness for this group. Effective smoking - cessation support needs to be tailored to the characteristics of pregnancy and reflect the key quit - smoking motivations of this group, such as the desire to protect the baby and the limited time frame.

### Research Methods
This study is a secondary analysis of data from two large MiQuit randomized controlled trials (RCTs). Participants were recruited from 40 NHS hospital maternity clinics in England, were aged 16 or above, were pregnant for no more than 25 weeks, smoked at least 5 cigarettes per day before pregnancy, and currently smoked at least 1 cigarette. Participants were randomly assigned to the usual care group (UC) or the MiQuit intervention group. In addition to usual care, the MiQuit intervention group received a 12 - week customized text - message support program.

### Main Findings
- **Short - term effects**: MiQuit significantly increased the self - reported 7 - day quit rate 4 weeks later (OR = 1.73 [95% CI 1.10–2.74]), but the effect in late pregnancy was only nearly significant (OR = 1.34 [0.99–1.82]).
- **Long - term effects**: MiQuit had no significant effect on continuous quit or biochemically verified quit.
- **Influence of baseline factors**: The degree of baseline tobacco dependence (mild vs. moderate - to - severe) and quit - smoking motivation (high vs. low) had no significant moderating effect on the effect of MiQuit, but the effect was greater in the high - motivation subgroup.
- **Mechanisms of action**: MiQuit had a small positive effect on the average use of relapse - prevention strategies (MiQuit 8.6 [SE 0.17], UC 8.1 [SE 0.17]; P =.030), but had no significant effect on other mechanisms.

### Conclusions
MiQuit increased the short - term self - reported quit rate, especially the 7 - day quit rate 4 weeks later, but had no significant effect on continuous quit or biochemically verified quit. MiQuit may be more effective for pregnant women with higher quit - smoking motivation. To enhance the effect, additional support components may need to be added.